Development of a breakthrough vaccine researchers say could eradicate breast cancer by 2030 wrapped up phase one of its clinical trial this week, with more than 75% of women showing a strong immune ...

The new artificial blood is shelf stable for two years and can be used on patients of any blood type. Mr. Chiaramonte was an ...

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that ...

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

Readers respond to an article about gene editing and object to cuts in research funding. Also: The Covid vaccine; Senator ...